Back to BANK OF AMERICA CORP /DE/ BANK OF AMERICA CORP /DE/

CNTACNTA
7 quarters

Position history for BANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/'s holdings in CENTESSA PHARMACEUTICALS PLC

BANK OF AMERICA CORP /DE/ previously held 0 shares of CNTA (CENTESSA PHARMACEUTICALS PLC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$732,109

Total Shares Change

-43,708

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$40.50
0
2026-Q1
Increased
1.9M
+103.5%
$76.8M0.0%$26.20
48
2025-Q4
Increased
949,544
+71.7%
$23.7M0.0%$24.74
43
2025-Q3
Increased
553,007
+307.2%
$13.4M0.0%$24.40
45
2025-Q2
Decreased
135,798
-34.4%
$1.8M0.0%$13.13
0
2025-Q1
Increased
207,028
+373.7%
$3M0.0%$14.59
43
2024-Q4
New
43,708
-
$732,1090.0%$16.35
34

Other major holders of CNTA: Avoro Capital Advisors LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Pentwater Capital Management LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used